NCT06578234View on ClinicalTrials.gov

Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses

PHASE4RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Coronary SyndromeCoronary Artery DiseaseIschemic Heart Disease
Interventions
DRUG

Adenosine

Standard dose 140 μg/kg/min and high dose 210 μg/kg/min adenosine

Trial Locations (1)

Unknown

RECRUITING

Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund

All Listed Sponsors
lead

Region Skane

OTHER